Bio-Rad Laboratories BIO
NYSE BIO
$376.85 -3.27 (-0.86%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) Net Margin Growth (1y) (2010 - 2026)

Analysis

Bio-Rad Laboratories (BIO) Net Margin Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Thermo Fisher Scientific 225.48 Bn 221.41 Bn 8.34 Bn -25.00
2 Danaher 144.42 Bn 140.08 Bn 3.61 Bn 454.00
3 Agilent Technologies 40.86 Bn 39.11 Bn 1.04 Bn -6.00
4 Illumina 30.97 Bn 29.80 Bn 770.00 Mn -433.00
5 Revvity 13.85 Bn 12.83 Bn 416.87 Mn -39.00
6 Bio-Techne 11.27 Bn 11.01 Bn 211.39 Mn 3,872.00
7 Bio-Rad Laboratories 10.11 Bn 8.49 Bn 345.80 Mn 828.00
8 Repligen 9.33 Bn 8.31 Bn 110.04 Mn -570.00
9 10x Genomics 8.77 Bn 8.21 Bn 112.50 Mn -3,185.00
10 Bruker 8.30 Bn 8.09 Bn 416.00 Mn -845.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 828.00
Mar 31, 2026 -9,995.00
Dec 31, 2025 21,110.00
Sep 30, 2025 -15,290.00
Jun 30, 2025 38,793.00
Mar 31, 2025 -5,192.00
Dec 31, 2024 -15,858.00
Sep 30, 2024 8,373.00
Jun 30, 2024 -16,851.00
Mar 31, 2024 5,266.00
Dec 31, 2023 -6,201.00
Sep 30, 2023 4,072.00
Jun 30, 2023 -3,678.00
Mar 31, 2023 49,117.00
Dec 31, 2022 32,695.00
Sep 30, 2022 -54,976.00
Jun 30, 2022 -26,155.00
Mar 31, 2022 -61,546.00
Dec 31, 2021 -32,085.00
Sep 30, 2021 32,271.00